AstraZeneca says newer vaccines have led to a decline in demand for its COVID-19 vaccine, which is no longer being ...

Add Yahoo as a preferred source to see more of our stories on Google. Covishield was developed by the British-Swedish company in collaboration with Oxford University, UK, and produced by the Serum ...

ZURICH (Reuters) - U.S. regulators have recommended pausing the use of Johnson & Johnson's COVID-19 vaccine as they investigate rare blood clotting in six women, including one who died. J&J also said ...

As countries in Europe and elsewhere continue to pause administration of the AstraZeneca COVID-19 vaccines over reports of clotting events in recipients, the European Medicines Agency (EMA) announced ...

Rare medical events draw intense attention during any mass vaccination campaign. Among COVID vaccine side effects, few stories triggered more concern than unusual clotting after certain shots. Doctors ...

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. A surplus of "available ...

After an all-day meeting that ran beyond its scheduled end, the safety committee of the European Medicines Agency (EMA) concluded Thursday that the benefits of receiving the AstraZeneca COVID-19 ...

OSLO (Reuters) - Three health workers in Norway who had recently received the AstraZeneca COVID-19 vaccine are being treated in hospital for bleeding, blood clots and a low count of blood platelets, ...

LONDON — Europe's medicines regulator found a possible link between the coronavirus vaccine developed by AstraZeneca and the University of Oxford and rare blood clotting issues — though it said the ...